ReproCELL Incorporated (TYO:4978)
Japan flag Japan · Delayed Price · Currency is JPY
192.00
+15.00 (8.47%)
Mar 6, 2026, 3:30 PM JST

ReproCELL Revenue

ReproCELL had revenue of 635.00M JPY in the quarter ending December 31, 2025, a decrease of -15.11%. This brings the company's revenue in the last twelve months to 2.52B, down -7.32% year-over-year. In the fiscal year ending March 31, 2025, ReproCELL had annual revenue of 2.98B with 22.75% growth.

Revenue (ttm)
2.52B
Revenue Growth
-7.32%
P/S Ratio
7.22
Revenue / Employee
25.44M
Employees
99
Market Cap
18.18B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20252.98B552.00M22.75%
Mar 31, 20242.43B-527.00M-17.85%
Mar 31, 20232.95B719.00M32.18%
Mar 31, 20222.23B948.00M73.72%
Mar 31, 20211.29B87.00M7.26%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Kidswell Bio7.06B
RaQualia Pharma3.98B
Immuno-Biological Laboratories1.03B
Stella Pharma968.00M
AnGes874.00M
CellSeed161.00M
Nano Holdings155.00M
Renascience107.00M
Revenue Rankings